Sergei Gryaznov
Fortuna: 64 650 $ al 31/05/2026
Fortuna: 64 650 $ al 31/05/2026
Sergei M.
Gryaznov is the founder of Lynx Therapeutics, Inc. (1993).
Current job includes Chief Scientific Officer at MAIA Biotechnology, Inc. (2019 - present).
Former jobs include Chemistry Director at Geron Corp.
(2013) and Chief Technology Officer at Exicure Operating Co. Education includes graduate and doctorate degrees from Moscow State University Lomonosov.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC. 0,08 % | 01/06/2026 | 46.511 ( 0,08 % ) | 64 650 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Director Técnico/Científico/I+D | 01/12/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01/01/2013 |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Corporate Officer/Principal | 01/01/1997 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.